These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 4101619)
1. The hypothalamus, brain-catecholamines, and drug therapy for gigantism and acromegaly. Sherman L; Kolodny HD Lancet; 1971 Apr; 1(7701):682-5. PubMed ID: 4101619 [No Abstract] [Full Text] [Related]
2. Acromegaly treated with chlorpromazine. A case study. Kolodny HD; Sherman L; Singh A; Kim S; Benjamin F N Engl J Med; 1971 Apr; 284(15):819-22. PubMed ID: 5549804 [No Abstract] [Full Text] [Related]
4. Hypothalamic mass and gigantism in neurofibromatosis: treatment with bromocriptine. Duchowny MS; Katz R; Bejar RL Ann Neurol; 1984 Mar; 15(3):302-4. PubMed ID: 6426370 [TBL] [Abstract][Full Text] [Related]
6. Neural regulation of growth hormone secretion. Martin JB Med Clin North Am; 1978 Mar; 62(2):327-36. PubMed ID: 347196 [No Abstract] [Full Text] [Related]
7. Evidence that acromegaly is not a hypothalamic disease. Allen JP; Cook DM; Greer MA; Paxton H; Castro A Trans Assoc Am Physicians; 1973; 86():272-83. PubMed ID: 4363384 [No Abstract] [Full Text] [Related]
8. [Growth hormone in health and disease]. Jelavić N Lijec Vjesn; 1971; 83(9):1079-83. PubMed ID: 5154075 [No Abstract] [Full Text] [Related]
9. [Discussion of biological criteria and evaluation of therapeutic results in the relation between acromegaly and J. Hardy's gigantism]. Schaub C; Franchimont P Neurochirurgie; 1974; 20(5):421-30. PubMed ID: 4377578 [No Abstract] [Full Text] [Related]
11. Disappearance rate of endogenous and exogenous human growth hormone in man. Refetoff S; Sönksen PH J Clin Endocrinol Metab; 1970 Mar; 30(3):386-92. PubMed ID: 5412545 [No Abstract] [Full Text] [Related]
12. [Long-term therapy of acromegaly and gigantism by using CB-154]. Aizawa T; Tawada M; Koizumi Y; Ikejiri K; Kotani M Horumon To Rinsho; 1977 Dec; 25(12):1310-5. PubMed ID: 598032 [No Abstract] [Full Text] [Related]
13. Acromegaly and gigantism. Hartog M Practitioner; 1980 Feb; 224(1340):149-51. PubMed ID: 7367366 [No Abstract] [Full Text] [Related]
14. Gigantism and somatostatin neurons. Dalrymple AM J Neurosurg; 1995 Jun; 82(6):1100-1. PubMed ID: 7760191 [No Abstract] [Full Text] [Related]
15. [A case of acromegaly-gigantism of nervous origin]. DE GENNES L; BRICAIRE H; WEISSENBACH R; WEILL-FAGE JC Bull Mem Soc Med Hop Paris; 1953 Apr 17-24; 69(13-14):384-7. PubMed ID: 13066999 [No Abstract] [Full Text] [Related]
16. [Growth hormones and their clinical use]. Shizume K; Irie M; Sakuma M; Tsushima T Naika; 1967 Sep; 20(3):404-15. PubMed ID: 4871764 [No Abstract] [Full Text] [Related]
17. Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study. Tahara S; Murakami M; Kaneko T; Shimatsu A Endocr J; 2017 Jul; 64(7):735-747. PubMed ID: 28592706 [TBL] [Abstract][Full Text] [Related]
18. [Acromegaly-gigantism. Clinical and biological study]. Somma M; Lanthier A Neurochirurgie; 1973 May; 19(2):Suppl 2:57-73. PubMed ID: 4752175 [No Abstract] [Full Text] [Related]
19. The role of brain catecholamines in the regulation of ACTH secretion. Van Loon GR Adv Neurol; 1974; 5():479-86. PubMed ID: 4374068 [No Abstract] [Full Text] [Related]